Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial
JAMA · 2025;334(22):1988-1999 · IF ≈ 63
Multicenter RCT in 86 centers / 19 countries. 1,467 adults in the first 4h of septic shock, randomized to a personalized hemodynamic protocol guided by CRT (n=720) vs. usual care (n=747). Primary outcome: hierarchical composite (mortality, duration of vital support, hospital length of stay) via win ratio.
Reported data
n=1,467Hierarchical composite (mortality, vital support duration, LOS)
28 daysWins at the death tier of the hierarchy (not a mortality rate)
28 daysWins at the vital-support duration tier
28 daysNot reportedarm-level mortality rates · component-level effect estimates with confidence intervals